Mirle Schemionek-Reinders (Mirle Schemionek)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 4

Top Topics

Helicobacter Pylori Infection

Chronic Myeloid Leukemia

Tyrosine Kinase

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Melanie Langhammer, Julia Schöpf, Timo Jaquet, Katharina Horn, Moritz Angel, Corinna Spohr, Daniel Christen, Franziska Maria Uhl, Tiago Maié, Henrike Jacobi, Thorsten B Feyerabend, Julia Huber, Marcus Panning, Cassian Sitaru, Ivan G Costa, Robert Zeiser, Konrad Aumann, Heiko Becker, Till Braunschweig, Steffen Koschmieder, Khalid Shoumariyeh, Michael Huber, Mirle Schemionek-Reinders, Tilman Brummer, Sebastian Halbach
Mast cell deficiency prevents BCR::ABL1 induced splenomegaly and cytokine elevation in a CML mouse model. Leukemia (2023)
Oliver Parting, Samantha Langer, Maja Kim Kuepper, Caroline Wessling, Shaoguang Li, Till Braunschweig, Nicolas Chatain, Tiago Maié, Ivan G Costa, Martina Crysandt, Michael Huber, Tim Henrik Brümmendorf, Steffen Koschmieder, Mirle Schemionek-Reinders
Therapeutic inhibition of FcγRIIb signaling targets leukemic stem cells in chronic myeloid leukemia. Leukemia 34 (10) (2020)
Oliver Herrmann, Maja Kim Kuepper, Marlena Bütow, Ivan G Costa, Iris Appelmann, Fabian Beier, Tom Luedde, Till Braunschweig, Steffen Koschmieder, Tim H Brümmendorf, Mirle Schemionek-Reinders
Infliximab therapy together with tyrosine kinase inhibition targets leukemic stem cells in chronic myeloid leukemia. BMC cancer 19 (1) (2019)
Tatjana Bilich, Annika Nelde, Leon Bichmann, Malte Roerden, Helmut R Salih, Daniel J Kowalewski, Heiko Schuster, Chih-Chiang Tsou, Ana Marcu, Marian Christoph Neidert, Maren Lübke, Jonas Rieth, Mirle Schemionek-Reinders, Tim Henrik Brümmendorf, Vladan Vucinic, Dietger Niederwieser, Jens Bauer, Melanie Märklin, Janet K Peper, Reinhild Klein, Oliver Kohlbacher, Lothar Kanz, Hans-Georg Rammensee, Stefan Stevanović, Juliane Sarah Walz
The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy. Blood 133 (6) (2018)